BioMarin Begins Phase II Study Of 6R-BH4 For Sickle Cell Disease
Firm initiates treatment in sickle cell patients after stalling Phase IIb study of molecule in treatment of hypertension earlier this year.
Firm initiates treatment in sickle cell patients after stalling Phase IIb study of molecule in treatment of hypertension earlier this year.